Downstaging of a gastric GIST by neoadjuvant imatinib and endoscopic assisted laparoscopic resection

European Journal of Surgical Oncology

Volumn 33, Issue 8, 2007, Pages 1044-1046

  Cavaliere, D ^a   Vagliasindi, A ^a   Mura, G ^a   Framarini, M ^a   Giorgetti, G ^a   Solfrini, G ^a   Tauceri, F ^a   Padovani, F ^a   Milandri, C ^a   Dubini, A ^a   Ridolfi, L ^a   Ricci, E ^a   Verdecchia, G M ^a  

^a MORGAGNI PIERANTONI HOSPITAL   (Italy)

Author keywords

Gastric neoplasm; Gastrointestinal stromal tumours (GISTs); Imatinib; Laparoscopic resection

Indexed keywords

IMATINIB;

ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER STAGING; CASE REPORT; ENDOSCOPIC SURGERY; GASTROINTESTINAL STROMAL TUMOR; GASTROSCOPY; HISTOPATHOLOGY; HUMAN; LAPAROSCOPIC SURGERY; MALE; OPERATION DURATION; PRIORITY JOURNAL; STOMACH BIOPSY; STOMACH TUMOR; SURGICAL APPROACH; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

GASTROINTESTINAL STROMAL TUMORS; HUMANS; LAPAROSCOPY; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; PIPERAZINES; PROTEIN KINASE INHIBITORS; PYRIMIDINES; STOMACH NEOPLASMS; TREATMENT OUTCOME;

EID: 34548636678     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2007.03.011     Document Type: Article

References (11)

1. Fletcher C., Berman J.J., and Corless C. Diagnosis of gastrointestinal stromal tumours: a Consensus approach. Hum Pathol 33 (2002) 459-465
2. Van Oosterom A.T., Judson I., Verweij J., et al. Safety and efficacy of imatinib (ST571) in metastatic gastrointestinal stromal tumours: a phase I study. Lancet 358 (2001) 1421-1423
3. Demetri G.D., von Mehren M., Blanke C.D., et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumours. N Engl J Med 347 7 (2002 Aug 15) 472-480
4. Verwej J., Casali P., Zalcberg J., et al. Early efficacy comparison of two doses of imatinib for the treatment of advanced gastrointestinal stromal tumor (GIST): interim results of a randomized phase III trial from the EORTC-STBSG, ISG and AGITG. Proc Am Soc Clin Oncol 22 (2003) 814
5. Hohenberger P., Bauer S., Schneider U., et al. Tumor resection following imatinib pre-treatment in GI stromal tumors. Proc Am Soc Clin Oncol 22 (2003) 818
6. Eisemberg B.L., and Judson I. Surgery and imatinib in the management of GIST: emerging approach to adjuvant and neoadjuvant therapy. Ann Surg Oncol 11 (2004) 465-475
7. Blanke C.D., Eisemberg B.L., and Heinrich M.C. Gastrointestinal stromal tumors. Curr Treat Options Oncol 2 (2001) 485-491
8. Blay J.Y., Bonvalot S., Casali P., et al. GIST consensus meeting panellists: consensus meeting for the management of gastrointestinal stromal tumor. Report of the GIST consensus Conference of 20-21 March 2004, under the auspice of ESMO. Ann Oncol 16 (2005) 566-578
9. Demetri G.D., Benjamin R., Blanke C.D., et al. NCCN Task force report: optimal management of patients with gastrointestinal stromal tumors (GIST) - expansion and update of the NCCN clinical practice guidelines. J Natl Compr Canc Netw 2 Suppl 1 (2004) S1-S26
10. Matthews B.D., Walsh R.M., Kercher K.W., et al. Laparoscopic vs open resection of gastric stromal tumors. Surg Endosc 16 5 (2002) 803-807
11. Bouillot J.L., Bresler L., Fagnez P.L., Samama G., Champault G., and Parent Y. Laparoscopic resection of benign submucosal gastric tumors. Gastroenterol Clin Biol 27 (2003) 272-276